Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
635.5000 3.90 (0.62%)
NSE Oct 03, 2025 15:31 PM
Volume: 509.8K
 

635.50
0.62%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 11% YoY to | 335 crore (I-direct estimate: | 320 crore) due to strong performance in development & manufacturing services and sustained growth in dedicated R&D; centres Gross margins improved 204 bps YoY to 76.1% but EBITDA margins declined 99 bps to 33.9% YoY (I-direct estimate: 33%) mainly due to higher employee expenses. EBITDA in value terms grew 7.5% YoY to | 114 crore (I-direct estimate: | 106 crore)...
Number of FII/FPI investors decreased from 332 to 279 in Jun 2025 qtr
More from Syngene International Ltd.
Recommended